MedTrace Logo

MRI to Detect Breast Tumors in Women

NCT00003302 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2019-09-25

No results posted yet for this study

Summary

RATIONALE: New imaging procedures, such as MRI, may improve the ability to detect breast tumors.

PURPOSE: Diagnostic study to determine the value of MRI in detecting breast tumors in women who have had suspicious mammographic or clinical examinations.

Conditions

Interventions

PROCEDURE

biopsy

DIAGNOSTIC_TEST

magnetic resonance imaging

DIAGNOSTIC_TEST

mammography

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Mitchell Schnall, PhD · Abramson Cancer Center at Penn Medicine

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-05-31
Primary Completion
2000-06-30
Completion
2000-06-30

Countries

  • United States
  • Canada
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003302 on ClinicalTrials.gov